Brief: Kronos Bio Shares Open About 50% Above IPO Price In Nasdaq Debut
Oct 9 (Reuters) -
* KRONOS BIO SHARES OPEN AT $28.50 IN NASDAQ DEBUT VERSUS IPO PRICE OF
$19.00/SHARE
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems